Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 3 of 3 results for deferiprone

  1. Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID4015]

    In development [GID-TA11250] Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Chronic iron overload (in people with thalassaemia) - desferrioxamine, deferiprone and deferasirox [ID350]

    Discontinued [GID-TAG423]

    Technology appraisal guidance
    Discontinued

  3. Betibeglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID968]

    Discontinued [GID-TA10334]

    Technology appraisal guidance
    Discontinued